ZAROXOLYN Drug Patent Profile
✉ Email this page to a colleague
When do Zaroxolyn patents expire, and when can generic versions of Zaroxolyn launch?
Zaroxolyn is a drug marketed by I3 Pharms and is included in one NDA.
The generic ingredient in ZAROXOLYN is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zaroxolyn
A generic version of ZAROXOLYN was approved as metolazone by SANDOZ on December 19th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZAROXOLYN?
- What are the global sales for ZAROXOLYN?
- What is Average Wholesale Price for ZAROXOLYN?
Summary for ZAROXOLYN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 87 |
| Clinical Trials: | 7 |
| Patent Applications: | 4,019 |
| What excipients (inactive ingredients) are in ZAROXOLYN? | ZAROXOLYN excipients list |
| DailyMed Link: | ZAROXOLYN at DailyMed |
Recent Clinical Trials for ZAROXOLYN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Maryland | Phase 4 |
| University of Maryland, Baltimore | Phase 4 |
| University of Virginia | Phase 4 |
US Patents and Regulatory Information for ZAROXOLYN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I3 Pharms | ZAROXOLYN | metolazone | TABLET;ORAL | 017386-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| I3 Pharms | ZAROXOLYN | metolazone | TABLET;ORAL | 017386-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| I3 Pharms | ZAROXOLYN | metolazone | TABLET;ORAL | 017386-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
